Jim Simons
IOVA icon

Jim Simons’s Iovance Biotherapeutics IOVA Stock Holding History

Jim Simons’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-651,000
Closed -$1.78M – 3461
2025
Q4 		$1.78M Buy
+651,000
New +$1.51M ﹤0.01% 1936
2025
Q3 		– Sell
-4,887,200
Closed -$8.41M – 3695
2025
Q2 		$8.41M Buy
4,887,200
+1,375,800
+39% +$3.42M 0.01% 1179
2025
Q1 		$11.7M Buy
+3,511,400
New +$18.1M 0.02% 926
2023
Q4 		– Sell
-1,226,400
Closed -$5.58M – 3904
2023
Q3 		$5.58M Sell
1,226,400
-506,300
-29% -$3.31M 0.01% 1236
2023
Q2 		$12.2M Sell
1,732,700
-142,800
-8% -$1.02M 0.02% 925
2023
Q1 		$11.5M Sell
1,875,500
-1,325,400
-41% -$9.14M 0.02% 1023
2022
Q4 		$20.5M Buy
3,200,900
+2,392,300
+296% +$18.7M 0.03% 699
2022
Q3 		$7.75M Buy
+808,600
New +$9.33M 0.01% 1166
2022
Q1 		– Sell
-270,000
Closed -$5.15M – 4255
2021
Q4 		$5.15M Buy
+270,000
New +$5.94M 0.01% 1513
2021
Q2 		– Sell
-140,600
Closed -$4.45M – 3616
2021
Q1 		$4.45M Buy
+140,600
New +$5.83M 0.01% 1718
2019
Q4 		– Sell
-61,400
Closed -$1.12M – 3616
2019
Q3 		$1.12M Buy
+61,400
New +$1.36M ﹤0.01% 2553
2016
Q4 		– Sell
-19,000
Closed -$156K – 3344
2016
Q3 		$156K Buy
+19,000
New +$161K ﹤0.01% 3110

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Jim Simons's IOVA Position: Q1 2026 in Review

Jim Simons sold out of Iovance Biotherapeutics (IOVA) in Q1 2026, closing a stake of 651,000 shares — an estimated $1.78M sold.

Jim Simons first reported a position in IOVA in Q3 2016 and held it in 12 quarters. The position peaked at $20.5M in Q4 2022. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Jim Simons reported no remaining Iovance Biotherapeutics position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 651,000 Iovance Biotherapeutics shares in Q1 2026, an estimated $1.78M.
  • Jim Simons first reported a position in Iovance Biotherapeutics in Q3 2016 and held it in 12 quarters.
  • Jim Simons's Iovance Biotherapeutics position peaked at $20.5M in Q4 2022.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.